Sri Kosuri of Octant - The Future of Drugs, Synthetic Biology, and Complex Diseases

In this episode of Build The Future, we talk with Sri Kosuri, CEO & co-founder of Octant. At Octant they engineer biology to design multi-targeted small molecule drug leads to transform the treatment of society’s most complex diseases.  We talk about their drug discovery engine, engineering biology, genetics, advances in biotech, and much more!Links Mentioned Octant Launches Polypharmacology Drug Discovery Engine for Complex Diseases with $30 Million Series A Financing Led by Andreessen Horowitz article on biospace.comTo listen to more episodes and stay connected, follow along at:https://www.buildthefuturepodcast.com/https://twitter.com/camwieseDon’t forget to leave a review and subscribe.Have a great week and until next time, go build!Thanks for joining us for this episode of the Build The Future Podcast! Podcast Info:Website: https://www.buildthefuturepodcast.com/Apple Podcasts: https://podcasts.apple.com/us/podcast/build-the-future/id1516358690Spotify: https://open.spotify.com/show/4gV7PsoAzDlil4jAKpSrYmYoutube Full Episodes: https://www.youtube.com/@worldsfaircoGet in touch, recommend guests, or say hello:X: https://twitter.com/camwieseEmail: podcast [at] worldsfair.co This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit camwiese.com